IPG Investment Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$349K Sell
2,702
-13,125
-83% -$1.54M 0.05% 181
2026
Q1
$1.92M Buy
15,827
+13,667
+633% +$1.58M 0.33% 63
2025
Q4
$229K Buy
+2,160
New +$203K 0.04% 194
2023
Q3
– Sell
-9,067
Closed -$1.05M – 172
2023
Q2
$1.05M Buy
9,067
+5,196
+134% +$590K 0.23% 64
2023
Q1
$415K Buy
+3,871
New +$418K 0.09% 99
2022
Q3
– Sell
-3,031
Closed -$278K – 168
2022
Q2
$278K Sell
3,031
-121
-4% -$10.7K 0.07% 115
2022
Q1
$261K Buy
3,152
+555
+21% +$43.8K 0.05% 135
2021
Q4
$201K Buy
+2,597
New +$207K 0.04% 184
2021
Q1
– Sell
-2,662
Closed -$208K – 207
2020
Q4
$208K Buy
+2,662
New +$204K 0.05% 155

Other funds holding MRK

IPG Investment Advisors's MRK Position: Q2 2026 in Review

IPG Investment Advisors reduced its Merck (MRK) stake by 83% in Q2 2026, selling an estimated $1.54M and leaving 2,702 shares worth $349K. The position accounts for 0.05% of the portfolio, ranked #181.

IPG Investment Advisors first reported a position in MRK in Q4 2020 and has held it in 9 quarters since. The position peaked at $1.92M in Q1 2026. 3,852 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • IPG Investment Advisors held 2,702 shares of Merck worth $349K as of Q2 2026.
  • IPG Investment Advisors sold 13,125 Merck shares in Q2 2026, an estimated $1.54M.
  • Merck made up 0.05% of IPG Investment Advisors's portfolio in Q2 2026, its #181 holding.
  • IPG Investment Advisors first reported a position in Merck in Q4 2020 and has held it in 9 quarters since.
  • IPG Investment Advisors's Merck position peaked at $1.92M in Q1 2026.
  • 3,852 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on IPG Investment Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.